Company Overview of Ontario Institute For Cancer Research
101 College St Suite 800
Toronto, ON M5g 1l7
Founded in 2001
Key Executives for Ontario Institute For Cancer Research
President and Scientific Director
Deputy Director and Chief Scientific Officer
Compensation as of Fiscal Year 2014.
Ontario Institute For Cancer Research Key Developments
Ontario Institute for Cancer Research Extends Collaboration with Janssen Inc. to Develop Clinical Trials for Prostate Cancer
Feb 25 15
The Ontario Institute for Cancer Research (OICR) is extending its collaborative research partnership with Janssen Inc. to develop more multi-centre clinical trials and other translational research projects that address important clinical questions in prostate cancer. The new funds will be made available to qualifying researchers at cancer centres across Canada who are addressing important clinical questions in prostate cancer. The funding will be dispersed to researchers through the Canadian Cancer Clinical Trials Network, which is based at OICR, through an open application process.
Ontario Institute For Cancer Research Presents at BioJapan 2013 World Business Forum, Oct-09-2013
Sep 25 13
Ontario Institute For Cancer Research Presents at BioJapan 2013 World Business Forum, Oct-09-2013 . Venue: Pacifico Yokohama, Yokohama, Japan.
Ontario Institute for Cancer Research Appoints Robert N. Klein to the Board of Directors
Jun 20 13
The Board of Directors of the Ontario Institute for Cancer Research announced the appointment of Robert N. Klein to OICR's Board of Directors. He served as Chairman of the Governing Board of CIRM for its first seven years and was elected Chairman Emeritus for the organization in 2011.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries